(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in ...

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) officially describes vision loss caused by reduced blood flow to the optic nerve ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...